NLS Pharmaceutics AG (NLSPW)

AI Score

Unlock

0.00

-0.00 (-100.00%)

At close: Apr 21, 2025, 9:30 AM

0.00

0.00%

After-hours: Apr 21, 2025, 04:00 PM EDT

NLS Pharmaceutics Balance Sheet Statement

Financials in USD. Fiscal year is undefined.

Fiscal Year	Q2 2024	Q4 2023	Q2 2023	Q4 2022	Q2 2022	Q4 2021	Q2 2021	Q4 2020	Q2 2020	Q4 2019	Q2 2019	Q4 2018
Period Ending	Jun 30, 2024	Dec 31, 2023	Jun 30, 2023	Dec 31, 2022	Jun 30, 2022	Dec 31, 2021	Jun 30, 2021	Dec 31, 2020	Jun 30, 2020	Dec 31, 2019	Jun 30, 2019	Dec 31, 2018
Cash & Equivalents	552.76K	897.68K	1.65M	8.95M	1.35M	5.43M	7.09M	93.71K	145.4K	220.27K	1.22M	6.68K
Short-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Long-Term Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	67.95K	56.19K	54.47K	55.27K	n/a
Other Long-Term Assets	0.00	16.89K	12.56K	12.14K	11.73K	12.04K	-1	946.91K	362.53K	260.21K	1.00	55.47K
Receivables	31.57K	10.66K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	75.39K	n/a	9.36K
Inventory	1.00	n/a	-64.28K	-41.24K	-59.83K	-38.55K	-43.08K	-61.21K	n/a	n/a	n/a	n/a
Other Current Assets	310.85K	n/a	102.1K	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Current Assets	1.19M	1.82M	2.25M	9.25M	2.02M	5.72M	8.24M	196.71K	221.28K	381.75K	1.32M	90.16K
Property-Plant & Equipment	990.00	6.69K	12.4K	18.1K	23.81K	29.51K	27.73K	n/a	n/a	n/a	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	990.00	23.58K	24.95K	30.25K	35.54K	41.55K	27.73K	1.01M	418.72K	314.68K	55.27K	55.47K
Total Assets	1.19M	1.85M	2.27M	9.28M	2.06M	5.76M	8.27M	1.21M	640K	696.43K	1.37M	145.63K
Account Payables	4.58M	4.63M	3.11M	2.37M	2.52M	1.74M	527.2K	4.01M	2.76M	2.51M	1.85M	1.13M
Deferred Revenue	n/a	n/a	n/a	n/a	n/a	2.5B	n/a	2.5B	n/a	-1	n/a	n/a
Short-Term Debt	1.71M	1.63M	n/a	n/a	354.34K	n/a	n/a	1.77M	792.85K	690.07K	683.83K	707.68K
Other Current Liabilities	277.77K	112.64K	-19.32K	8.89K	33.24K	10.08K	n/a	56.84K	289.7K	12.39K	n/a	30.15K
Total Current Liabilities	7.72M	7.92M	3.89M	3.36M	3.41M	2.4M	1.19M	7.2M	4.72M	4.04M	2.92M	2.41M
Long-Term Debt	n/a	n/a	n/a	n/a	n/a	n/a	n/a	313.48K	574.94K	152.06K	n/a	6.39M
Other Long-Term Liabilities	243.63K	260.68K	164.62K	136.12K	188.76K	318.89K	327.32K	178.27K	177.64K	180.25K	150.77K	159.02K
Total Long-Term Liabilities	2.74M	2.76M	2.66M	2.64M	2.69M	2.82M	2.83M	2.99M	3.25M	2.83M	2.65M	6.54M
Total Liabilities	10.46M	10.68M	6.56M	6M	6.1M	5.22M	4.02M	10.2M	7.97M	6.87M	5.57M	8.96M
Total Debt	1.71M	1.63M	n/a	n/a	354.34K	n/a	n/a	2.08M	1.37M	842.13K	683.83K	7.09M
Common Stock	808.55K	733.41K	733.41K	668.55K	411.27K	344.44K	259.73K	145.14K	145.14K	145.14K	145.14K	133.54K
Retained Earnings	-72.41M	-70.37M	-65.81M	-58.2M	-50.35M	-41.71M	-34.36M	-29.76M	-28.13M	-26.9M	-24.87M	-21.45M
Comprehensive Income	4.21K	-158.07K	-66.22K	-50.79K	-32.71K	-151.74K	-179.85K	-19.38K	-18.7K	-18.7K	-11.25K	-11.25K
Shareholders Equity	-9.27M	-8.83M	-4.29M	3.28M	-4.04M	542.39K	4.25M	-8.98M	-7.33M	-6.17M	-4.2M	-8.81M
Total Investments	n/a	n/a	n/a	n/a	n/a	n/a	n/a	67.95K	56.19K	54.47K	55.27K	n/a